Free Trial
OTCMKTS:GNGBY

Getinge AB (publ) (GNGBY) Stock Price, News & Analysis

$19.28
+0.07 (+0.36%)
(As of 07/26/2024 ET)
Today's Range
$19.19
$19.31
50-Day Range
$16.77
$19.49
52-Week Range
$16.54
$22.80
Volume
10,274 shs
Average Volume
17,635 shs
Market Capitalization
N/A
P/E Ratio
24.41
Dividend Yield
1.24%
Price Target
N/A
GNGBY stock logo

About Getinge AB (publ) Stock (OTCMKTS:GNGBY)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

GNGBY Stock Price History

GNGBY Stock News Headlines

Getinge AB (publ) (OTCMKTS:GNGBY) Releases Earnings Results
Dave Ramsey Makes Big Mistake Live On Air
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
Getinge (0GZV) Receives a Hold from Kepler Capital
GNGBY Getinge AB ADR
Dave Ramsey Makes Big Mistake Live On Air
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
GNGBF Getinge AB (publ)
Getinge AB (GNGBF) Q1 2024 Earnings Call Transcript
Getinge AB's Dividend Analysis
Here's what to expect from Getinge AB's earnings
Getinge AB Series B
Getinge AB (publ) (GNGBY)
See More Headlines
Receive GNGBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Getinge AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/14 Dividend
4/23/2024
Dividend Payable
5/14/2024
Last Earnings
7/18/2024
Today
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:GNGBY
CIK
N/A
Employees
11,386
Year Founded
N/A

Profitability

Net Income
$227.45 million
Pretax Margin
9.79%

Debt

Sales & Book Value

Annual Sales
$3.00 billion
Cash Flow
$1.63 per share
Book Value
$10.53 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.82
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Mattias Perjos M.Sc. (Age 52)
    CEO, President & Director
    Comp: $42.54M
  • Ms. Agneta Palmer (Age 46)
    Chief Financial Officer
  • Mr. Lars Mattsson
    Head of Investor Relations
  • Ms. Anna Romberg MSc Econ (Age 45)
    Executive Vice President of Sustainability, Legal & Compliance
  • Mr. Magnus Lundback Ph.D. (Age 55)
    Executive Vice President of Human Resources
  • Mr. Carsten Blecker (Age 58)
    Chief Commercial Officer
  • Mr. Stephane Le Roy (Age 47)
    President of Surgical Workflows
  • Mr. Eric Honroth (Age 53)
    President of Life Science
  • Ms. Patricia A. Fitch
    President of North America Region
  • Ms. Elin Frostehav (Age 42)
    President of Acute Care Therapies

GNGBY Stock Analysis - Frequently Asked Questions

How have GNGBY shares performed this year?

Getinge AB (publ)'s stock was trading at $22.2340 at the start of the year. Since then, GNGBY shares have decreased by 13.3% and is now trading at $19.28.
View the best growth stocks for 2024 here
.

How were Getinge AB (publ)'s earnings last quarter?

Getinge AB (publ) (OTCMKTS:GNGBY) announced its quarterly earnings data on Thursday, July, 18th. The company reported $0.21 earnings per share for the quarter. The business earned $776.85 million during the quarter. Getinge AB (publ) had a trailing twelve-month return on equity of 8.56% and a net margin of 7.76%.

How do I buy shares of Getinge AB (publ)?

Shares of GNGBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GNGBY) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners